Formulation and Intervention Effect Analysis of Evaluation Criteria for Alanyl-glutamine Rational Use in Our Hospital / 中国药房
China Pharmacy
; (12): 1133-1135, 2017.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-510076
Responsible library:
WPRO
ABSTRACT
OBJECTIVE:
To explore the effect of clinical pharmacist intervention on the rational use of Alanyl-glutamine injection.METHODS:
Referring to package inserts of Alanyl-glutamine injection,Clinical Pharmacy Consensus of Parenteral Nutrition,ASPEN Nutrition Therapy Guidelines for Critically Ill Patients,related domestic and foreign literatures,evaluation criteria for Alanyl-glutamine injection rational use was formulated.After collecting Alanyl-glutamine injection cases (497 cases) in the second quarter of 2015 and those cases (385 cases) in the second quarter of 2016,rational use of Alanyl-glutamine injection were analyzed comparatively before and after intervention.RESULTS:
The utilization rate and irrational rate of Alanyl-glutamine injection were 4.6% and 52.9% before intervention as well as 2.9% and 10.9% after intervention,with statistical significance (P<0.05).There was statistical significance in hyper-indication,excessive concentration of drug liquid,excessive supply of amino acid,irrational compatibility and solvent selection,long treatment course before and after intervention (P<0.05).CONCLUSIONS:
Clinical pharmacists reduce irrational rate of drug use and guarantee safe and effective drug use through formulating evaluation criteria for Alanyl-glutamine injection rational use and providing pharmaceutical intervention on rational use of Alanyl-glutamine injection.
Full text:
Available
Database:
WPRIM (Western Pacific)
Type of study:
Practice guideline
Language:
Chinese
Journal:
China Pharmacy
Year:
2017
Document type:
Article